glp 1 rheumatoid arthritis Microdosing GLP-1 for Arthritis: Evidence and Safety Glucagon-like peptide and its receptor

Millions of Americans have used Ozempic, Wegovy, Mounjaro or other glucagon-like peptide-1 receptor agonists (GLP-1 RA) drugs in recent years, amid aggressive promotions by the drug makers that indicated the medications were safe and effective for weight loss

Some suppliers label it one way, others label it differently

Both are taken daily, but the more frequent the dosing, the more patients may have to deal with gastrointestinal side effects, says Jacob Jeppesen, Alveuss chief scientific officer

The FDA prescribing information for the structurally related tirzepatide (Mounjaro) notes that "co-administration with insulin secretagogues or insulin may increase the risk of hypoglycemia" [2], and that same caution applies broadly to incretin-class drugs including investigational agents